<DOC>
	<DOCNO>NCT01921127</DOCNO>
	<brief_summary>This study intend evaluate treatment effectiveness BFC compare FSC COPD patient new ICS/LABA combination therapy .</brief_summary>
	<brief_title>Comparative Effectiveness Symbicort vs. Advair Among COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Continuous health plan enrollment 12 month index Rx , least one prescription BFC FSC intake period , naive ICS/LABA therapy year prior first prescription claim , COPD diagnosis , age 40 time first prescription . ICS/LABA combination preindex period , patient claim BFC FSC day , patient diagnose cancer , patient longterm OCS medication use preindex period .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>COPD , Comparative effectiveness , Symbicort</keyword>
</DOC>